Helminthiasis Pregnancy and Childbirth
Conditions
Interventions
Albendazole
Empty caplets
Sponsors
Dr Afusat Olabinjo
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: • All consenting pregnant women with singleton foetus presenting between 14 and 26 weeks.
Exclusion criteria
Exclusion criteria: • Non consenting pregnant women. • Patients with known hypersensitivity to benzimidazole. • Baseline haemoglobin concentration less than 7g/dl. • Patients with multiple gestations. • Patients with sickle cell disease • Patients with chronic kidney disease. • Retroviral disease patients. • Patients that may require blood transfusion during the course of pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maternal stool parasite density | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes will be determined by maternal anaemia and neonatal birth weight, APGAR scores NICU admission and still birth. | — |
Countries
Nigeria
Contacts
Public ContactPeter Aboyeji
Professor
Outcome results
None listed